Conclusions:
- There is an implicit assumption that early detection fo hypertension through screening can reduce the burden of morbidity and mortality, but this assumption has not been tested in rigorous research studies
- High-quality evidence from RCTs or programmatic evidence from NRCTs on the effectiveness and costs or harms of different screening strategies for hypertension (mass, targeted, or opportunistic) to reduce hypertension-related morbidity and mortality is lacking
Read the review: Screening strategies for hypertension